Thrombosis

Affiliations

Rahmi Oklu. Cardiovasc Diagn Ther. 2017 Dec.

. 2017 Dec;7(Suppl 3):S131-S133.

doi: 10.21037/cdt.2017.11.08.

¹ Division of Vascular & Interventional Radiology, Mayo Clinic, Phoenix, AZ, USA. (Email: oklu.rahmi@mayo.edu).

No abstract available

Conflict of interest statement

Conflicts of Interest: The author has no conflicts of interest to declare.

1. Behravesh S, Hoang P, Nanda A, et al. Pathogenesis of Thromboembolism and Endovascular Management. Thrombosis 2017;2017:3039713. 10.1155/2017/3039713 - DOI - PMC - PubMed
1. Prandoni P, Kahn SR. Post-thrombotic syndrome: prevalence, prognostication and need for progress. Br J Haematol 2009;145:286-95. 10.1111/j.1365-2141.2009.07601.x - DOI - PubMed
1. Cohen AT, Hamilton M, Mitchell SA, et al. Comparison of the Novel Oral Anticoagulants Apixaban, Dabigatran, Edoxaban, and Rivaroxaban in the Initial and Long-Term Treatment and Prevention of Venous Thromboembolism: Systematic Review and Network Meta-Analysis. PLoS One 2015;10:e0144856. 10.1371/journal.pone.0144856 - DOI - PMC - PubMed
1. Tapson VF, Humbert M. Incidence and prevalence of chronic thromboembolic pulmonary hypertension: from acute to chronic pulmonary embolism. Proc Am Thorac Soc 2006;3:564-7. 10.1513/pats.200605-112LR - DOI - PubMed
1. Heit JA, Mohr DN, Silverstein MD, et al. Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med 2000;160:761-8. 10.1001/archinte.160.6.761 - DOI - PubMed